Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease
Published: June 16, 2014
- Under-treatment and under-testing in women lead to increased complications and to higher rate of case fatalities.
- Atherosclerotic coronary artery disease (CAD) continues to be underrecognized and underdiagnosed in women, contributing to the high mortality
- This statement provides modern evidence to assist in identifying the appropriate female candidates for diagnostic testing.
Supporting Materials
Recommended Reading
- Fifteen-Year Trends in Awareness of Heart Disease in Women (PDF)
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update (PDF)
- Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women (PDF)
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- Management of Patients With Atrial Fibrillation (PDF)
- Heart Disease and Stroke 2014 Statistical Update